Fidem Pharmaceuticals Inc. – Trademark Portfolio

Entity Type: 03

Fidem Pharmaceuticals Inc. holds 15 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 14 filings in this category. The portfolio also extends into Class 41 (Education & Entertainment) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include SERAPHIM SUPPLEMENTS. The owner is based in Cottleville, MO.

P.O. Box 441

Cottleville, MO 63338

15 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Fidem Pharmaceuticals Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (14 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

41
Education & Entertainment (1 filing)

Education; providing of training; entertainment; sporting and cultural activities

Frequently Asked Questions

How many trademarks does Fidem Pharmaceuticals Inc. have?

Fidem Pharmaceuticals Inc. has 15 U.S. trademarks filed with the USPTO. Of these, 1 registered, 5 abandoned, 9 cancelled.

What trademark classes does Fidem Pharmaceuticals Inc. file in?

Fidem Pharmaceuticals Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 41 (Education & Entertainment). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Fidem Pharmaceuticals Inc.'s most well-known trademarks?

Fidem Pharmaceuticals Inc.'s registered trademark portfolio includes well-known marks such as SERAPHIM SUPPLEMENTS. These are among 1 currently registered trademark in the portfolio.

What is Fidem Pharmaceuticals Inc.'s trademark registration success rate?

Fidem Pharmaceuticals Inc. has a 7% trademark registration rate, with 1 out of 15 resolved applications resulting in successful registration. Currently, 0 applications are pending review.